Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Brenda Weigel, MD
Children's Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
105 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Children'S Hospital at Westmead
Westmead, New South Wales, Australia
- Royal Brisbane and Women'S Hospital
Herston, Queensland, Australia
- Royal Children'S Hospital
Parkville, Victoria, Australia
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- British Columbia Children'S Hospital
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Janeway Child Health Centre
St. John's, Newfoundland and Labrador, Canada
- Iwk Health Centre
Halifax, Nova Scotia, Canada
- Hospital for Sick Children
Toronto, Ontario, Canada
- Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Southern California Permanente Medical Group
Downey, California, United States
- Miller Children'S Hospital
Long Beach, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Children'S Hospital Central California
Madera, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Childrens Hospital of Orange County
Orange, California, United States
- Lucile Packard Children'S Hospital Stanford University
Palo Alto, California, United States
- University of California San Francisco Medical Center-Parnassus
San Francisco, California, United States
- Connecticut Children'S Medical Center
Hartford, Connecticut, United States
- Alfred I Dupont Hospital for Children
Wilmington, Delaware, United States
- Lombardi Comprehensive Cancer Center at Georgetown University
Washington D.C., District of Columbia, United States
- Lee Memorial Health System
Fort Myers, Florida, United States
- Nemours Children'S Clinic - Jacksonville
Jacksonville, Florida, United States
- Miami Children'S Hospital
Miami, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Florida Hospital
Orlando, Florida, United States
- Nemours Childrens Clinic - Orlando
Orlando, Florida, United States
- Uf Cancer Center at Orlando Health
Orlando, Florida, United States
- Nemours Children'S Clinic - Pensacola
Pensacola, Florida, United States
- All Children'S Hospital
St. Petersburg, Florida, United States
- Saint Joseph Children'S Hospital of Tampa
Tampa, Florida, United States
- Saint Mary'S Hospital
West Palm Beach, Florida, United States
- Children'S Healthcare of Atlanta - Egleston
Atlanta, Georgia, United States
- University of Hawaii
Honolulu, Hawaii, United States
- Saint Luke'S Mountain States Tumor Institute
Boise, Idaho, United States
- Lurie Children'S Hospital-Chicago
Chicago, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2009
- Primary completion
- 30 Apr 2013
- Completion
- 31 Oct 2013
- Last update posted
- 30 Mar 2015
- Registered enrollment
- 116
- Registry id
- NCT00831844
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.